In May 2021, Pfizer and BioNTech inked a deal to supply Europe with up to 1.8 billion vaccine doses. Now, many member states, including Poland, want out of the contract. (Andrei Vasilev/iStock/Getty ...

The credit crunch has not put an end to major acquisitions by well-run companies that have a compelling strategic plan and a pile of cash. New York-based Pfizer, the world’s biggest drug maker, agreed ...

Drug maker Pfizer and the Ireland-based Allergan confirmed reports Monday that they were merging, creating the world’s largest pharmaceutical company with an estimated value of $160 billion. The move ...

Late in 2023 I believed that the potential was still there in the case of Pfizer (PFE) after another setback in the pipeline. To see where Pfizer comes from, we really have to create some perspective, ...

Pfizer has agreed to acquire Metsera, a clinical-stage biopharmaceutical company. The transaction, announced Sept. 22, is valued at $47.50 per Metsera share in cash upon closing, for an initial ...

Late in October, I called Pfizer (PFE) an interesting stock, provided that discipline returned. The company was still working to obtain all the necessary approvals to acquire Seagen, its latest and ...